healthmedicinet

A cancer diagnosis is always devastating, though zero can be as a bad as a diagnosis of modernized metastatic cancer. 

This means your cancer is incurable. A new investigate was expelled this week that suggests some-more  younger women are being diagnosed with modernized incorrigible breast cancer. This during a time when cancer deaths have depressed 20 percent over a past 20 years.

The series of American women ages 25-39 being diagnosed with late theatre breast cancer has risen from 250 per year to 850 per year.  Wouldn’t it be good to have a “WHY” answered during a same time a investigate is released, or during slightest a devise of movement for what they intend to do to figure out a “WHY?”  

So many studies….so few answers.  Frustration abounds.  

What we do know is that this points again to a significance of continued investigate to answer a “why” and that is what we are doing during NFF (Noreen Fraser Foundation).

Last week, we presented a extend we gave to UCLA for investigate in a margin of epigenetics. Now, we will share with we earnest investigate we have postulated in Canada.

Our initial Canadian extend went to Drs. John Mackey Nadeem Pervez during a University of Alberta, Canada.  The extend was done probable due to a munificence of Stella Dot and a Canadian stylists who courteously upheld us by featuring a breast cancer recognition line of  beautiful pinkish products with a net deduction benefiting NFF during a whole month of October.  

The extend will account a commander plan to exam a feasibility of a new form of deviation diagnosis for women with early theatre breast cancer.  

Pervez and his group are questioning a new therapy, that involves implanting hot seeds into a breast of early theatre breast cancer patients following a lumpectomy so that patients might equivocate a normal deviation diagnosis that requires daily sanatorium visits for 7 to 12 weeks,  and that can be unpleasant and disfiguring.  

If a commander proves successful, patients might have a new diagnosis format that is safer, some-more effective, pain-free and most some-more available than normal deviation treatment.  You can review some-more about a investigate here.

NFF’s Winter Challenge is good on a way!  We have already lifted $2,000 this past week toward a fundraising idea of $53,000 to continue a work during a epigentics lab during UCLA. To those of we who have contributed, appreciate we so much.  You can make a secure, online concession by clicking here.   

As always, 100 percent of online donations to a NFF go directly toward groundbreaking women’s cancer research.  
 

Noreen Fraser is vital with Stage IV metastatic breast cancer. She is a Founder and CEO of a Noreen Fraser Foundation, a 501(c)(3) non-profit classification dedicated to appropriation groundbreaking women’s cancer research. To stay in hold with Noreen, greatfully ‘LIKE’ The Noreen Fraser Foundation on Facebook and follow her on Twitter.  Noreen can be contacted around email during [email protected].